88-92
FINALPhiladelphia
76ers
27-55|L10: 2-8
New
York Knicks
29-53|L10: 3-7
-
//
Sports
- All Players
- Seasons
Eastern Conference
Western Conference
More
Sign in
Sign in and connect Sleeper to unlock personalized fantasy insights.
Philadelphia 76ers
New York Knicks
| # | Team | W-L | Pct | GB |
|---|---|---|---|---|
| 1 | 61-21 | 0.744 | — | |
| 2 |
| Opponent | Date | Result |
|---|---|---|
| 3/17 | W 108-97 | |
| 3/15 |
| 58-23 |
| 0.716 |
| 2.5 |
| 3 | 53-28 | 0.654 | 7.5 |
| 4 | 49-32 | 0.605 | 11.5 |
| 5 | 46-35 | 0.568 | 14.5 |
| 6 | 46-36 | 0.561 | 15.0 |
| 7 | 41-40 | 0.506 | 19.5 |
| 8 | 40-41 | 0.494 | 20.5 |
| 9 | 32-50 | 0.390 | 29.0 |
| 10 | 89-148 | 0.376 | 49.5 |
| 11 | 29-53 | 0.354 | 32.0 |
| 12 | 27-55 | 0.329 | 34.0 |
| 13 | 27-55 | 0.329 | 34.0 |
| 14 | 26-56 | 0.317 | 35.0 |
| 15 | 0-0 | 0.000 | 20.0 |
| 3/14 | L 91-104 |
| 3/12 | L 95-100 |
| 3/10 | L 87-102 |
| Opponent | Date | Result |
|---|---|---|
| 3/17 | L 97-109 | |
| 3/15 | W 94-84 | |
| 3/13 | W 128-94 | |
| 3/12 | L 112-119 | |
| 3/10 | L 87-97 |
| Player | PointsPPG | FG% | 3P% | FT% |
|---|---|---|---|---|
| 17.1 | 44.4% | 31.5% | 67.0% | |
| 14.0 | 46.2% | 31.3% | 75.0% | |
| 13.9 | 39.9% | 20.0% | 73.4% |
| Player | PointsPPG | FG% | 3P% | FT% |
|---|---|---|---|---|
| 20.2 |
| 54.9% |
| 0.0% |
| 73.2% |
| 17.7 | 42.7% | 31.6% | 69.0% |
| 15.3 | 47.1% | 21.2% | 56.7% |
| Category | NYK Offense | PHI Defense | Advantage |
|---|---|---|---|
Offensive RatingPoints scored per 100 possessions | #1187.2 ORtg | #23109.4 DRtg | NYK |
Turnover RateLower offensive turnovers vs defensive forced turnovers | #1311.5% | #1214.6% | Even |
3P% vs AllowedPerimeter efficiency vs perimeter defense | #1734.8% | #2839.5% | NYK |
| Category | NYK Defense | PHI Offense | Advantage |
|---|---|---|---|
Offensive RatingPoints allowed per 100 possessions | #25109.9 DRtg | #1983.7 ORtg | NYK |
Turnover RateDefensive takeaways vs offensive giveaways | #1114.6% | #2111.9% | NYK |
3P% vs AllowedPerimeter defense vs perimeter shooting | #1335.2% | #2333.9% | PHI |
